Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 621

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 2
Chunk 621
---
 on estimated fair values. Accordingly, the fair value estimates disclosed, or initial
amounts recorded, may not be indicative of the amount that the Company or holders of the instruments could realize in a current market
exchange.

    F-9

The
carrying amounts of the Company’s financial instruments including cash and cash equivalents, prepaid expenses, accounts payable
and accrued liabilities approximate fair value due to the short-term maturities of these instruments.

Set
out below are the Company’s financial instruments that are required to be remeasured at fair value on a recurring basis and their
fair value hierarchy as of December 31, 2024 and 2023:

 Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

    December 31, 2024 
    Level 1  
    Level 2  
    Level 3  
    Carrying Value 
  
    Assets 

    Marketable Securities: 

    United States Treasury Bonds 
    $—  
    $—  
    $—  
    $— 
  
    Total Assets 
    $—  
    $—  
    $—  
    $— 
  
    Liabilities 

    Derivative Liability - Warrants 
    $—  
    $—  
    $25,281  
    $25,281 
  
    Derivative Liability - Accelerated feature 
     —  
     —  
     —  
     — 
  
    Convertible Note 
    $—  
    $—  
    $684,205  
    $684,205 
  
    Total Liabilities 
    $—  
    $—  
    $709,486  
    $709,486 

    December 31, 2023 
    Level 1  
    Level 2  
    Level 3  
    Carrying Value 
  
    Assets 

    Marketable Securities: 

    United States Treasury Bonds 
    $2,887,215  
    $—  
    $—  
    $2,887,215 
  
    Total Assets 
    $2,887,215  
    $—  
    $—  
    $2,887,215 
  
    Liabilities 

    Derivative Liability - Warrants 
    $—  
    $—  
    $410,660  
    $410,